News
01
2022-03
BrosMed Enters 10th Anniversary Year
BrosMed Medical Co., Ltd.(“BrosMed”) is celebrating its 10 year anniversary today!
2022-03-01
19
2021-11
With the support from you and all our colleagues, BrosMed MEDICA 2021 has crowned with complete success and made a grand exposure from 15-18 November. Thank you for visiting our booth and Let’s looking forward to meet at next MEDICA 2022!
2021-11-19
01
2021-06
Brosmed receives CE mark approval for POT™ PTCA balloon catheter
Sittard, Netherlands [May 24, 2021] –Brosmed, a medical device company developing and commercializing innovative interventional treatment systems for patients with coronary and peripheral disease today announced she received CE Mark approval in the European Union for its POT™ PTCA balloon catheter, a dedicated balloon for the proximal and distal optimization technique(PDOT).
2021-06-01
26
2021-05
Brosmed receives CE mark approval for Pronavi™ Microcatheter
Sittard, Netherlands [May 26, 2021] –Brosmed, a medical device company developing and commercializing innovative interventional treatment systems for patients with coronary and peripheral disease today announced she received CE Mark approval in the European Union for its Pronavi™ Microcatheter .Device is indicated for use in both coronary and peripheral interventions.
2021-05-26
24
2021-05
Guangdong ,China [May 24 , 2021] – Brosmed Ltd. today announced that she has received a 510(k) clearance from the U.S. Food & Drug Administration for its Artimes™ Pro PTCA balloon catheter. Artimes™ Pro is a novel PTCA semi-compliant rapid-exchange balloon dilatation catheter manufactured with specific features to facilitate complex coronary interventions.
2021-05-24
11
2021-05
Optimize Percutaneous Coronary Intervention with a Scoring Balloon Webinar
Guangdong [May 11 , 2021] – Brosmed Medical Ltd. hosted its first global webinar: Optimize Percutaneous Coronary Intervention with a Scoring Balloon on April 27th 2021. This webinar was hosted by Prof. Stephane Carlier from Belgium together with Dr. Bernardo Cortese from Italy and Prof. Jo Dens from Hart Center Genk in Belgium.
2021-05-11
07
2021-04
Artimes™ Pro Clinical Trial Completed Successfully in U.S.
A clinical trial of Artimes™ Pro, a rapid exchange coronary balloon dilatation catheter manufactured by BrosMed Medical, has been successfully completed in the United States. The diameters of the balloon dilatation catheters are 1.0 mm and 1.25 mm. The crossing profile of 1.0mm balloon is ultra-small of 0.0218’’, which is suitable for CTO lesions.
2021-04-07
05
2020-06
BrosMed obtained CE certificate for Interventional Accessories
May 27th, 2020—BrosMed Medical Co., Ltd. announced that the CE and ISO certificates for 10 interventional accessories have been obtained at the same time!This is the 4th CE certificate after Alveo High pressure Balloon Catheter, Wedge NC scoring balloon catheter and the Tri-Wedge PTA Scoring Balloon Catheter. This shows Brosmed achieves another milestone in interventional area.
2020-06-05